CAS: 1007-99-4; 2-Amino-4-Chloro-6-Hydroxy-5-Nitropyrimidine

该化合物是一个属于火林家族的环状有机化合物,该化合物的特征是:一个以氨氨基化合物,一个氯组,一个氢氧化物组和一个硝基化合物组替代的火水晶环,这对其独特的化学特性有帮助;其典型特征是,它处于稳固的室温状态,由于水氧组的存在,极地溶剂中存在中等溶解性;由于存在多种功能组,它成为有机合成的多功能体中间体,特别是在制药和农用化学物的开发方面;其硝基化合物组可以参与各种化学反应,包括减少和替代,而氨基和氢氧化物组可以参与氢的联结,影响其与生物系统的再活性和相互作用;安全数据表明,应该谨慎地处理它,因为它在接触时可能构成健康风险.

结构式图片

相似化合物

3137-56-2 4214-85-1 51471-45-5

欧盟法规

C&L通报

上下游产品

CAS号1194-21-4 2-氨基-4-氯-6-羟基嘧啶 | CAS号114113-85-8 2-amino-6-(4,4-... | CAS号80466-56-4 2-氨基-4,6-二羟基-5-硝基嘧啶 | CAS号51471-45-5 N-(6-氯-5-硝基-4-氧...

合成工艺路线路线简述

    📜2-氨基-6-氯-4-羟基嘧啶置于硫酸,Potassium Nitrate体系中,化学反应 1.5H,以72%的收率获得2-氨基-4-氯-5-硝基-6-羟基嘧啶
    参考文献:二氨基亚甲基氨基羰基二硝基甲烷,是在硝化2-氨基-6-氯-4(3 H)-嘧啶酮的过程中形成2-氨基-6-氯-5-硝基-4(3 H)-嘧啶酮的过程中形成的
    标题:二氨基亚甲基氨基羰基二硝基甲烷,是在硝化2-氨基-6-氯-4(3 H)-嘧啶酮的过程中形成2-氨基-6-氯-5-硝基-4(3 H)-嘧啶酮的过程中形成的
    摘要:显示出硝化2-氨基-6-氯-4(3 H)-嘧啶酮的困难,得到广泛使用的杂环前体2-氨基-6-氯-5-硝基-4(3 H)-嘧啶酮由于形成了不寻常的开链宝石-二硝基化合物,被鉴定为二氨基亚甲基氨基羰基二硝基甲烷.后者也通过2-氨基-4,6(3 H,5 H)-嘧啶二酮的硝化反应形成.它在二甲基亚砜或氢氧化钾水溶液中损失二氧化碳而分解,得到胍和二硝基甲烷.
    Doi:10.1016/s0040-4039(00)02360-1

    专利信息


    专利号:US-5350851-A
    优先权日:1992-03-16
    标题 :Intermediates and a process for synthesis of tetrahydropteridine C6-stereoisomers, including (6S)-tetrahydrofolate and N5-formyl-(6S)-tetrahydrofolate
    发明人:BAILEY STEVEN W; AYLING JUNE E
    权利人:UNIV SOUTH ALABAMA
    摘要:Intermediates and a process for the synthesis of 6-monosubstituted tetrahydropteridine C6-stereoisomers, including (6S)-tetrahydrofolic acid. The intermediates are shown in their two enantiomeric forms as follows: ##STR1## wherein R 1 and R 2 are the same or different and represent hydrogen, methyl, hydroxy, amino, alkyl or dialkylamino, alkoxy, benzyloxy, or benzylthio; R 3 represents an alkene, alkyne, cycloalkyl, benzyl, alkyl (substituted with hydroxy, acetoxy, benzyloxy, alkoxy, alkylthio, amino, carboxy, oxo, or phosphate), a protected aldehyde, or ##STR2## wherein n=1 or 2, R 4 is hydrogen, formyl, methyl, or propargyl, and ZZ represents an amino acid or amino acid polymer.

    专利号:US-3959278-A
    优先权日:1970-07-27
    标 题 :Method of synthesis of pteridines
    发明人:WOOD HAMISH CHRISTOPHER SWAN; STUART ALEXANDER; CURRAN ADRIAN CHARLES WARD; AL-HASSAN SAIEBA
    权利人:BURROUGHS WELLCOME CO
    摘要:A pharmaceutical formulation of a compound of formula (II') ##SPC1## n wherein Y is a lower alkyl group, in association with a pharmaceutically acceptable carrier, as an antibacterial product, and methods involving the preparation and reductive cyclization of a compound of formula (IV) ##SPC2## n wherein X is a lower alkyl group or a hydroxymethyl group.

    专利号:US-5401844-A
    优先权日:1983-04-11
    标 题 :Regulation of enzymes which utilize tetrahydrobiopterin or tetrahydrofolate cofactors with 6,6-disubstituted-tetrahydropteridines
    发明人:AYLING JUNE E; BAILEY STEVEN W
    权利人:UNIV SOUTH ALABAMA
    摘要:6-[2'-Amino-2',2'-disubstituted-ethylamino]-pyrimidines of the structure: ##STR1## in which X=H, NH 2 or NO 2 , which are novel intermediates in the synthesis of quinoid 6,6-disubstituted-dihydro- and 6,6-disubstituted-tetrahydro-pteridines, are claimed.

    专利号:US-11912734-B2
    优先权日:2020-01-28
    标题:Solid-phase synthesis of oligonucleotides containing N6-(2-deoxy-alpha,beta-derythropentofuranosyl)-2,6-diamino-4-hydroxy-5-formamidopyrimidine (Fapyâ‹…dG)
    发明人:GREENBERG MARC M; YANG HAOZHE
    权利人:UNIV JOHNS HOPKINS
    摘要:A strategy using reverse phosphoramidites for synthesizing oligonucleotides containing Fapy·dG is disclosed.

    专利号:US-2011124634-A1
    优先权日:2008-05-13
    标 题:Bioactive compounds for treatment of cancer and neurodegenerative diseases
    发明人:SUN CONNIE L; LI XIAOYUAN
    权利人:PONIARD PHARMACEUTICALS INC
    摘要:The invention provides bioactive compounds for the treatment of various malconditions such as cancer and neurodegenerative diseases including Alzheimer's disease. The chemical compounds as disclosed herein are found to show bioactivity in bioassays related to these conditions. Pharmaceutical compositions, combinations and methods of synthesis are provided, as are methods of using the compound, compositions and combinations in the treatment of the diseases.

    专利号:ES-2397104-T3
    优先权日:2002-12-11
    标 题 :Procedure and intermediate products for the synthesis of entecavir

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:von Angerer, S., Science of Synthesis Knowledge Updates, (2011) 1, 335.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知